Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Recruiting

InvestigationalNo placebo

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Golimumab

Contact Research Centre

Crohn's disease

Recruiting

Investigational

A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Crohn's disease

Recruiting

Investigational

A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

A study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy

Investigational

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

A study testing duvakitug for patients with moderately to severely active ulcerative colitis

Investigational

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Migraine

Recruiting

Registered drug

Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins

Contact Research Centre

Migraine

Recruiting

Registered drug

Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins

Contact Research Centre

Cardiovascular disorder+2

Recruiting

Registered drug

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Bi 690517

Contact Research Centre

Arteriosclerosis

Recruiting

Investigational

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide

Contact Research Centre

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Recruiting

Registered drug

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Baxdrostat

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study comparing Rilvegostomig plus chemotherapy versus Pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you

122 trials match your criteria

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

Crohn's disease

A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease

Crohn's disease

A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease

Non-small cell lung cancer+1

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Colitis ulcerative

A study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy

Colitis ulcerative

A study testing duvakitug for patients with moderately to severely active ulcerative colitis

Migraine

Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

Migraine

Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Cardiovascular disorder+2

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Arteriosclerosis

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Non-small cell lung cancer

Study comparing Rilvegostomig plus chemotherapy versus Pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.